{"title":"Historical examination of tuberculosis; from ancient affliction to modern challenges","authors":"Seyyed Mohammad Amin Mousavi-Sagharchi , Atousa Ghorbani , Maryam Meskini , Seyed Davar Siadat","doi":"10.1016/j.jiph.2024.102649","DOIUrl":null,"url":null,"abstract":"<div><div>Tuberculosis (TB), white plague, many other definitions is an ancient deadly infection that humans dealt with after creation. The first hypothesis refers to 150 million years ago about the appearance of TB in the Jurassic era before human creation, but documents show 9000 years ago for first appearance in human society. In 1882, Robert Koch was able to identify and describe the best possible agent of TB. After the discovery of TB’s agent [<em>Mycobacterium tuberculosis</em>], progress was made in diagnosis and treatment rapidly, and invasive operations such as surgery were replaced with drug treatment and chemical compounds hired for treatment that were so effective before drug resistance occurrence. In this review authors done their tries to describe all aspects of TB [identification, epidemics, diagnostics, drug development, etc.] in history from ancient records to the present condition and give insight into the future of TB ending in 2030 and 2050.</div></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"18 3","pages":"Article 102649"},"PeriodicalIF":4.7000,"publicationDate":"2025-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Infection and Public Health","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1876034124003836","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Tuberculosis (TB), white plague, many other definitions is an ancient deadly infection that humans dealt with after creation. The first hypothesis refers to 150 million years ago about the appearance of TB in the Jurassic era before human creation, but documents show 9000 years ago for first appearance in human society. In 1882, Robert Koch was able to identify and describe the best possible agent of TB. After the discovery of TB’s agent [Mycobacterium tuberculosis], progress was made in diagnosis and treatment rapidly, and invasive operations such as surgery were replaced with drug treatment and chemical compounds hired for treatment that were so effective before drug resistance occurrence. In this review authors done their tries to describe all aspects of TB [identification, epidemics, diagnostics, drug development, etc.] in history from ancient records to the present condition and give insight into the future of TB ending in 2030 and 2050.
期刊介绍：
The Journal of Infection and Public Health, first official journal of the Saudi Arabian Ministry of National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences and the Saudi Association for Public Health, aims to be the foremost scientific, peer-reviewed journal encompassing infection prevention and control, microbiology, infectious diseases, public health and the application of healthcare epidemiology to the evaluation of health outcomes. The point of view of the journal is that infection and public health are closely intertwined and that advances in one area will have positive consequences on the other.
The journal will be useful to all health professionals who are partners in the management of patients with communicable diseases, keeping them up to date. The journal is proud to have an international and diverse editorial board that will assist and facilitate the publication of articles that reflect a global view on infection control and public health, as well as emphasizing our focus on supporting the needs of public health practitioners.
It is our aim to improve healthcare by reducing risk of infection and related adverse outcomes by critical review, selection, and dissemination of new and relevant information in the field of infection control, public health and infectious diseases in all healthcare settings and the community.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
